Chad Therapeutics Declares Stock Split

Chad Therapeutics Inc., a Chatsworth maker of oxygen-conserving devices used by pulmonary patients, declared a two-for-one stock split.

The split is effective for shareholders of record Oct. 1. The additional shares will be distributed Oct. 15.

Chad said the split increases its total shares outstanding to 6,174,416.